Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

For the First Time in Israel: A New Non-invasive Mitral Valve Replacement Procedure

Non-invasive Mitral Valve Replacement
Using the LAMPOON technique, a transcatheter mitral valve replacement procedure lowers risks and negates open-heart surgery.

For the first time in Israel, doctors at Sheba Medical Center performed a new, cutting-edge procedure on a patient with a malfunctioning mitral valve: a transcatheter mitral valve replacement (TMVR).

During a TMVR, doctors replace defective mitral valves with an artificial substitute through catheterization, using a new technique called LAMPOON, which prevents the obstruction of blood flow in the left ventricular outflow tract (LVOT): a common fatal complication of TMVR. The LAMPOON procedure involves inserting two catheters through blood vessels in the patient’s groin and up to the heart, then using an electrified wire woven through the catheter to split open the heart valve leaflet and replace the valve.

For elderly or frail patients, TMVR offers a less-invasive alternative to open-heart surgery. It was recently performed at Sheba on a 74-year-old patient who suffers from a cardiovascular connective tissue disease and underwent open-heart surgery 14 years ago.

The non-invasive procedure, which was completed successfully with no serious complications, was conducted by Sheba’s Prof. Victor Guetta, Director of the Invasive and Interventional Cardiology Unit, along with Prof. Israel Barbash, Director of Catheterization Services. Having extensive experience with the LAMPOON technique, Dr. Robert Lederman, Chief of the US National Heart, Lung, and Blood Institute, and Head of the Cardiovascular Intervention Laboratory, along with Dr. Adam Grinbaum, Co-Director of the Structural Heart and Valve Center at Emory University, monitored the procedure through bidirectional audiovisual telecommunication and guided the catheterization team in real-time.

According to Prof. Guetta, “The patient’s mitral valve deteriorated over time. Theoretically, he could have undergone another surgery, but since the patient already had an invasive open-heart surgery previously, there would be a greater chance of fatal complications.”

Prof. Israel Barbash added, for his part: “This procedure is a leap forward in our ability to offer treatment options to people who, until now, have been unable to receive proper care for this kind of illness.”

Sheba Ranked Among the Top 10 Hospitals in the World by Newsweek
We are pleased to announce that for the sixth consecutive year, Sheba has been recognized as one of the best hospitals in the world by…
Read More
Doctor analyzing hemophilia blood with a microscope. The focus of the shot is on the blood.
Breakthrough Hemophilia Treatment by Prof. Gili Kenet Empowers Boy's Dream
Prof. Gili Kenet, a renowned pediatric hematologist at Sheba’s National Hemophilia Center and an esteemed professor at the Sackler School of Medicine, unveiled a groundbreaking…
Read More
Text "SCIENCE DOSE" with a magnifying glass next to it zooming in on cells and viruses. Additional elements include a syringe, microscope, and blood cells.
Navigating Retinoblastoma: Expert Analysis by Prof. Didi Fabian
Prof. Didi Fabian, a senior ocular oncologist at Sheba’s Goldschleger Eye Institute and Director of Sheba Global Ophthalmology, recently delved into retinoblastoma, an eye cancer…
Read More